Compared to normal cells, cancer cells tend to have higher concentrations of reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) due to an accelerated cellular metabolism. The high ROS content leaves cancer cells increasingly susceptible to oxidative stress-induced cell death. This susceptibility can be manipulated in selective cancer therapy by further increasing production of ROS or inhibiting peroxide removal systems or a combination of the two.
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Introduction:
In the United States, pancreatic cancer accounts for 3% of all cancers and 7% of cancer deaths [1] . Pancreatic adenocarcinoma of ductal epithelial origin, comprises the majority of pancreatic cancer cases, and is the fourth leading cause of cancer deaths. The incidence of pancreatic cancer has been increasing slightly over the past decade [1] .
Surgical resection of the tumor is currently the only potentially curative treatment. However, less than 10% of patients are eligible for surgical resection, and median survival is only 12 to 18 months after resection. Additionally, fewer than 5% of patients survive 5 years following resection. Radiation and chemotherapy are common adjuvant therapies in the treatment of pancreatic cancer. Nevertheless, these therapies have failed to significantly improve long-term survival. Less than 10% of patients benefit from radiation while less than 20% respond to chemotherapy. Very few patients survive beyond 5 years, and most will ultimately die of metastatic recurrence [2] .
Almost all cancers, including pancreatic cancer have elevated levels of reactive oxygen species (ROS), promoting tumor development and progression [3] . High levels of ROS in cancer cells are often the result of increased metabolic activity as well as mitochondrial dysfunction [4] .
Normally, aerobic generation of energy occurs when molecular oxygen is reduced to water via the transfer of four electrons to oxygen. In principle, this reaction continues without production of intermediates. However, this reaction also generates partially reduced oxygen species.
Superoxide (O2 Damage caused by ROS is prevented and repaired by an antioxidant network (Figure 1 ).
The enzyme catalase can remove H2O2 present in high concentrations. In contrast, the selenium-dependent enzyme, Glutathione peroxidase (GPx) has high affinity for H2O2, and can remove it even when H2O2 is present at low concentrations. Glutathione (GSH) provides the electrons for GPx removal of H2O2 [7] . For every molecule of H2O2 removed, two molecules of glutathione donate an electron and are oxidized to glutathione disulfide (GSSG). Glutathione disulfide is known to be toxic to cells [8] . Glutathione disulfide reductase (GR) is responsible for recycling GSSG to maintain GSH levels. GR removes two electrons from NADPH, donating them to GSSG, regenerating cellular stores of GSH for further H2O2 removal [9] .
The GSH system is one of two major systems responsible for removal of H2O2. The other major peroxide removal system is the thioredoxin system. In this system, peroxiredoxin reduces H2O2 to H2O at the expense of thioredoxin [10] . Thioredoxin contains a catalytic site in which two neighboring cysteines are cycled between the active reduced dithiol and oxidized disulfide forms [4] . Thioredoxin reductase (TrxR) is then responsible for regeneration of the reduced dithiol form of thioredoxin, donating electrons obtained from NADPH [10] .
The antioxidant enzymes can be targeted either directly or indirectly via modulation of NADPH availability. NADPH is an important electron donor in the reduction of both GSSG and thioredoxin. Energy from the conversion of glucose-6-phosphate into ribulose-5-phosphate during glycolysis is utilized during the oxidative phase of the pentose phosphate cycle to reduce two molecules of NADP + to NADPH. 2-deoxyglucose (2-DG) is a glucose analog in which the 2-hydroxyl group is replaced by a hydrogen atom. This effectively prevents the molecule from undergoing glycolysis and allowing it to competitively inhibit the production of glucose-6-phosphate [11] . Glucose transporters facilitate the uptake of 2-DG. Many types of cancer cells tend to have higher glucose uptake than normal cells, and therefore have higher uptake of 2-DG [12] . For this reason, 2-DG has been investigated as a potential anti-cancer agent. Additionally, by inhibiting glycolysis, 2-DG indirectly prevents NADP + reduction to NADPH. Therefore, it may have an effect on the ability of GR and TrxR to reduce their substrates, GSSG and thioredoxin, respectively [13] .
Auranofin is an orally available organic gold compound traditionally used to treat rheumatoid arthritis. It is known to interact with selenol-containing residues, and inhibit thioredoxin reductase [14] . This inhibition of H2O2 removal is the rationale behind recent interest in auranofin use as an anticancer therapy.
Ascorbate (also known as Vitamin C and ascorbic acid) has been established as an effective reducing agent. It will readily undergo two one-electron oxidations, forming both ascorbate radical (Asc Ascorbate radical is relatively unreactive and readily dismutes to ascorbate and DHA [10, 15] .
These antioxidant properties of ascorbate are arguably its most well-known properties.
A normal, healthy human will typically have a plasma ascorbate concentration of 40-80 μM.
These are the levels at which ascorbate functions as an antioxidant [10] . At pharmacological .-which then dismutes to H2O2 and O2 [10] . High-dose intravenous ascorbate is well tolerated when administered to patients. Ascorbate concentrations of 25 mM were obtained in patients who received ascorbate (1.5 g/kg). As of July 2015, the mean survival of subjects completing at least 2 cycles (8 weeks) of therapy is now 15 ± 2 months compared to the historical controls of 6 months [16] .
Pharmacological ascorbate has been since shown to sensitize several cancer types to radiation therapy by increased production of ROS such as H2O2, overwhelming antioxidant systems [17] . Ascorbate is well-tolerated and seems to lack the normal cell toxicity of other cancer treatments, making it a promising adjuvant for cancer therapy.
One working model for the development of cancer therapeutics is the combination of inhibited peroxide removal and pro-oxidant pharmacological agents. This combination may sufficiently overwhelm antioxidants over the toxicity threshold [4] . We hypothesized that inhibition of peroxide-removal systems would enhance ascorbate-induced cytotoxicity in pancreatic cancer cells.
Methods:

Cell Culture
The pancreatic cancer cell line MiaPaCa-2 (ATCC) were cultured in DMEM (Gibco, 
Knockdown of Glutathione Reductase Expression
The following shRNA sequences targeting the glutathione reductase mRNA were designed by the University of Iowa Viral Vector core and were cloned downstream of the mU6 promoter: 
Western Blotting
Cells were collected by scraping; protein concentrations were determined using a Bio-Rad 
Glutathione Reductase Activity
Cells were collected by scraping and glutathione reductase activity measured using a 
Statistical Analysis
A single factor ANOVA followed by the Tukey post hoc test was used to determine statistical differences between means for multiple comparisons. A Student's t-test was used to determine statistical differences between means for two comparisons. All means were calculated from one or two independent experiments in triplicate, with error bars representing the SD. All data are expressed as mean ± SD.
Results:
Inhibition of Thioredoxin Reductase
Auranofin (AF) has been shown to interact with selenol-containing residues and inhibit TrxR [14] . MIA PaCa-2 pancreatic cancer cells treated with AF (1 μM) for 3 h showed that TrxR activity was significantly inhibited compared to vehicle-treated controls (Figure 2A) . After 24 h AF treatment, TrxR activity was not significantly different from activity following 3 h AF treatment (n = 3, P < 0.05).
Pharmacological ascorbate has been shown to induce cytotoxicity in pancreatic cancer cells via its oxidation and eventual production of H2O2 [2] . Therefore, inhibition of TrxR and resultant impairment of the thioredoxin peroxide removal system should enhance ascorbate-induced cytotoxicity in pancreatic cancer cells. When MIA PaCa-2 cells were treated with AF (1 μM) for 3
or 24 h and Asc (2 mM) for 1 h, the surviving fraction was significantly decreased compared to cells treated with AF alone (Figure 2B , n = 6, P < 0.01).
Inhibition of Glutathione Peroxidase System
Glutathione reductase (GR) activity is required for efficient peroxide removal by the glutathione peroxidase system. By removing two electrons from NADPH and donating them to GSSG, GR regenerates cellular stores of GSH. These stores provide electrons for the removal of H2O2 by glutathione peroxidase [9] .
To study the specific contributions of glutathione reductase inhibition to ascorbate-induced cytotoxicity, MIA PaCa-2 cells were transduced with a lentiviral vector encoding GR-targeted shRNA (GSR2 and GSR4) or a scrambled control vector (Scrambled). To determine the efficiency of GR knockdown, Western blot analysis and GR enzyme activity assays were performed. Cells transduced with GSR2 vector demonstrated decreased GR protein compared to non-transduced and Scrambled-transduced cells ( Figure 3A) . GR enzyme activity assays demonstrated a significant decrease in GR activity in GSR2-transduced cells compared to nontransduced controls and both Scrambled and GSR4-transduced cells ( Figure 3B , n = 3, P <
0.05).
To investigate the effect of GR knockdown on MIA PaCa-2 cell response to pharmacological ascorbate treatment, clonogenic survival assays were performed. Cells transduced with Scrambled, GSR2, and GSR4 vectors showed similar clonogenic survival when treated with 0 -1 mM concentrations of ascorbate for 1 h. When treated with 2 mM ascorbate, both GSR2 and GSR4 transduced cells showed significant decreases in clonogenic survival compared to
Scrambled vector transduced cells ( Figure 4A , n = 3, P < 0.05).
Previous studies from the laboratory have shown that pharmacologic ascorbate treatment enhances ionizing radiation (IR)-induced cytotoxicity in pancreatic cancer cells [17] . To determine whether inhibition of GR enhances ascorbate-induced radiosensitization, clonogenic survival assays were performed combining GR knockdown with pharmacological ascorbate and IR treatments. Neither scrambled nor GSR4-transduced MIA PaCa-2 cells showed significant differences between radiation alone and radiation with ascorbate (0.5 mM) treatments ( Figure   4B , 4D, two independent experiments, each in triplicate, P < 0.05). However, GSR2-transduced cells showed a significant decrease in surviving fraction when treated with both radiation (4 Gy) and ascorbate (0.5 mM) for 1 h (Figure 4C , two independent experiments, each in triplicate, P < 0.05).
Inhibition of Hydrogen Peroxide Removal Systems
2-Deoxy-Glucose (2-DG) is a glucose analog that competitively inhibits glucose metabolism, creating a chemically induced state of glucose deprivation, resulting in a decreased level of NADPH required for GR and TrxR activity, inhibiting hydroperoxide detoxification [11, 12] . The glutathione peroxidase system requires GR activity to efficiently remove peroxide [9] . To study the effects of decreased GR activity, we developed GSR2 and GSR4 lentiviral vectors encoding a GR-targeted shRNA to stably knockdown GR expression in MIA PaCa-2 pancreatic cancer cells. These vectors enabled us to decrease GR activity without additional off-target effects. The GSR2 lentiviral vector knocked down GR protein expression and significantly decreased GR activity in MIA PaCa-2 cells. Additionally, we showed that knockdown of GR in GSR2-transduced cells did not enhance ascorbate-induced cytotoxicity when treated with low dose (0-1mM) ascorbate alone. However, GSR2-transduced cells showed significant decreases in clonogenic survival when treated with both radiation and ascorbate. Conversely, GSR4 and scrambled vector transduced cells treated with ascorbate did not exhibit enhanced sensitivity to radiation compared to radiation alone. Hence, knockdown of GR protein expression and ascorbate increased radiosensitivity in MIA PaCa-2 pancreatic cancer cells.
The glucose analog, 2-DG competitively inhibits glucose metabolism, resulting in decreased NADPH. Because NADPH is required for GR and TrxR activity, this effectivity inhibits H2O2 metabolism by both the thioredoxin and glutathione peroxidase systems [11, 12] . In both MIA PaCa-2 and 403 F1 patient-derived pancreatic cancer cells, combination of 2-DG, ascorbate, and radiation therapy significantly decreased clonogenic survival compared to radiation alone. 339 patient-derived pancreatic cancer cells showed no difference in clonogenic survival between combination therapy and radiation alone. These data show that 2-DG and ascorbate increased radiosensitivity in some, but not all pancreatic cancer cell types. Unpublished data (Claire Doskey, personal communication, unreferenced; 
